Intervention Review

Depot pipotiazine palmitate and undecylenate for schizophrenia

  1. Mohandas Dinesh1,*,
  2. Anthony David2,
  3. Seema N Quraishi2

Editorial Group: Cochrane Schizophrenia Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 5 MAY 2004

DOI: 10.1002/14651858.CD001720.pub2

Database Title

Additional Information

How to Cite

Dinesh M, David A, Quraishi SN. Depot pipotiazine palmitate and undecylenate for schizophrenia. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD001720. DOI: 10.1002/14651858.CD001720.pub2.

Author Information

  1. 1

    Leeds Community Mental health Teaching NHS Trust, Psychiatry, Leeds, W Yorkshire, UK

  2. 2

    Institute of Psychiatry, London, UK

*Mohandas Dinesh, Psychiatry, Leeds Community Mental health Teaching NHS Trust, Department of Liaison Psychiatry, Becklin centre, Alma Street, Leeds, W Yorkshire, LS9 7BE, UK. dineshmohandas@hotmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (57K)Standard (330K)Full (524K)

  1. Current Version

    Depot pipotiazine palmitate and undecylenate for schizophrenia

    Mohandas Dinesh, Anthony David and Seema N Quraishi

    Article first published online: 7 OCT 2009 | DOI: 10.1002/14651858.CD001720.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Depot pipothiazine palmitate and undecylenate for schizophrenia

    A David and SN Quraishi

    Article first published online: 19 JUL 2004 | DOI: 10.1002/14651858.CD001720

View Full Article (HTML) Summary (57K)Standard (330K)Full (524K)